Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 00022 | Registry Identifier | Romanian Renal Registry |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Several studies revealed a direct relationship between the severity of periodontal inflammation and CRP (NHANES III, Dumitriu HT et al, 1998). In patients without any other source of inflammation but PDD, proper dental treatment of the disease decreased CRP to normal levels (Dumitriu H.T. et al., 1998; D'Aiuto F. et al, 2004; Borawski J. et al., 2007) Moreover, a direct link between high levels of CRP and atherosclerotic complications has been found in studies conducted both in general population (Ridker PM, et al., 1998; Koenig W, et al., 1999) and in HD subjects (Westhuyzen J, et al., 2000; Iseki K., et al., 1999; Zimmermann J, et al. 1998).
Patients will be recruited according to eligibility criteria. Initial oral and general status will be evaluated and recorded. The evaluated parameters are listed at the study description section. Also, quality of life will be assessed by using the SF-36 and OHIP-14 questionnaires.
Patients will undergo a series of dental interventions with the final scope of eliminating all oral inflammation. Participants will also be instructed regarding correct oral hygiene habits.
Following dental and periodontal treatments, the oral and general status will be reassessed and the obtained dat analysed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dental treatment | Assessment of the clinical state of the patient. Professional prophylaxis and removal of calculus. Extraction of hopeless teeth.Education of patient for oral hygiene. Periodic reevaluation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dental treatment | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Modification of nutritional status | SGA, whole body bioimpedance, biochemical parameters (serum albumin, predialysis serum urea, serum creatinine, serum phosphates) | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Modification of inflammatory status | C Reactive Protein | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Modification of periodontal disease index | Modification of periodontal disease index assessed by the CAL, PPD, bleeding index | 3 months |
| Modification of the quality of life, as assessed by SF-36 and OHIP-14 |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Haemodialyzed patients with Periodontal Disease
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Oana Slusanschi, DMD | Contact | +40722266279 | oanciu@yahoo.com | |
| Liliana Garneata, MD | Contact | +40722619358 | lilianagarna@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Oana Slusanschi, DMD | University of Medicine and Pharmacy Bucharest | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CMI "Dr Slusanschi Oana" | Recruiting | Bucharest | Romania |
Not provided
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| D051436 | Renal Insufficiency, Chronic |
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003729 | Dental Care |
| ID | Term |
|---|---|
| D003813 | Dentistry |
| D003752 | Dental Health Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Modification of the quality of life, as assessed by SF-36 and OHIP-14
| 6 months |
| Modification of anaemia response to epoetin | Modification of anaemia response to epoetin, as assessed by the ERI and by the cumulative ESAs dose | 6 months |
| D014570 |
| Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |